Stress and depression are associated with shorter survival in head and neck cancer patients
Studies have shown that stress can affect the immune system and weaken the body's defense against infection and disease. In cancer patients this stress can also affect a tumor's ability to grow and spread. However, the ...
Cancer
Apr 28, 2011 |
not rated yet |
0
|
VEGF may not be relevant biomarker for advanced prostate cancer
The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University ...
Cancer
Apr 29, 2013 |
not rated yet |
0
Age-related macular degeneration treatment works even with other eye problem
The primary treatment for wet macular degeneration, a chronic eye condition that causes vision loss, is effective even if patients have macular traction problems, a Mayo Clinic study shows. The findings will be presented ...
Ophthalmology
Nov 11, 2012 |
not rated yet |
0
Novel drug may stop eye disease
(Medical Xpress)—A new drug developed by researchers from Flinders University, in partnership with collaborators in Melbourne, could hold the key to better treatment of some blinding eye diseases.
Ophthalmology
Nov 01, 2012 |
not rated yet |
0
Mechanisms of action for green tea extract in breast cancer prevention identified
An oral green tea extract, Polyphenon E, appears to inhibit vascular endothelial growth factor and hepatocyte growth factor, both of which promote tumor cell growth, migration and invasion.
Cancer
Oct 18, 2012 |
5 / 5 (1) |
0
Study sheds light on bone marrow stem cell therapy for pancreatic recovery
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model ...
Medical research
Oct 02, 2012 |
not rated yet |
0
A form of small pox virus shows potential for treating triple-negative breast cancer
Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City have shown that a new vaccinia virus, acting as both an oncolytic and anti-angiogenic agent, can enter and kill triple-negative breast cancer ...
Cancer
Oct 01, 2012 |
not rated yet |
0
New drug candidate in diabetes research breakthrough
CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease.
Diabetes
Sep 26, 2012 |
5 / 5 (1) |
0
Skin and immune system influence salt storage and regulate blood pressure
High blood pressure is responsible for many cardiovascular diseases that are the leading cause of death in industrialized countries. High salt intake has long been considered a risk factor, but not every type of high blood ...
Medical research
Sep 08, 2012 |
5 / 5 (2) |
0
Zebrafish study explains why the circadian rhythm affects your health
Disruptions to the circadian rhythm can affect the growth of blood vessels in the body, thus causing illnesses such as diabetes, obesity, and cancer, according to a new study from Linköping University and ...
Medical research
Aug 28, 2012 |
3 / 5 (2) |
0
Metastatic breast cancer: Bevacizumab slows progression, but has no impact on survival
The cancer drug bevacizumab (Avastin) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed ...
Cancer
Jul 10, 2012 |
not rated yet |
0
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
For patients with metastatic soft-tissue sarcoma whose disease has progressed following standard chemotherapy, treatment with pazopanib (a drug that targets the growth of new cancer-related blood vessels) nearly tripled progression-free ...
Cancer
May 15, 2012 |
not rated yet |
0
Tivozanib exhibits antitumor activity in renal cancer
(HealthDay) -- The potent, selective vascular endothelial growth factor receptor-1, -2, and -3 inhibitor, tivozanib, demonstrates antitumor activity and is well tolerated in patients with advanced/metastatic ...
Cancer
Apr 10, 2012 |
not rated yet |
0
Study examines use of bevacizumab among patients with hereditary blood vessel disorder
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received ...
Diseases, Conditions, Syndromes
Mar 06, 2012 |
not rated yet |
0
High VEGF signaling score tied to lung cancer prognosis
(HealthDay) -- A high vascular endothelial growth factor (VEGF) signaling score correlates with good prognosis in patients with early squamous cell carcinoma (SCC) of the lung, according to a study published ...
Cancer
Feb 22, 2012 |
5 / 5 (1) |
0
